University of Texas Southwestern Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).

837 total trials 162 currently recruiting 503 completed early-phase tilt top decile by trial count

University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.

University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.

Top-decile sponsor footprint

University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

837 total, page 10 of 17

TERMINATED NA

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

NCT02535845

COMPLETED Phase 2

Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

NCT03318497

COMPLETED NA

Promoting Activity in Cancer Survivors

NCT03060941

COMPLETED

The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux

NCT04061018

COMPLETED NA

Implementing an IPTS Treatment Approach to Improve Outcomes in Suicidal Youth

NCT03527459

TERMINATED Phase 2

Anti-PD-L1 and SAbR for Ovarian Cancer

NCT03312114

TERMINATED Phase 1

High Dose Rate Brachyablation of Primary Liver Lesions

NCT02893982

TERMINATED NA

Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration

NCT03303391

COMPLETED NA

Wearable Sensor for Biometrics During Locoregional Therapy for Head and Neck Cancer

NCT03574870

COMPLETED Phase 2

Preventing Hypertension and Sympathetic Overactivation by Targeting Phosphate

NCT03234361

COMPLETED

Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)

NCT05459311

COMPLETED

Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer

NCT03386812

COMPLETED Phase 4

Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients

NCT03168308

COMPLETED NA

Saturation Targets and Resuscitation in Preterm Trial

NCT03115463

COMPLETED NA

Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System

NCT02943265

TERMINATED Phase 1

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

NCT02902484

COMPLETED NA

The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation

NCT03181334

COMPLETED

Transfusion of Whole Blood and Cesarean Delivery: A Retrospective Review

NCT03523780

TERMINATED Phase 1

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

NCT02574910

COMPLETED NA

Clinical-Decision Support to Improve Hypertension Care in Primary Care

NCT03404999

COMPLETED NA

Apneic Oxygenation With a Nasal Cannula in the Obese and Morbidly Obese Surgical Patient

NCT03671837

COMPLETED

Incidence of Postoperative Neuromuscular Blockade in Post-Anesthesia Care Unit at Parkland Hospital: Does Size Matter?

NCT03111082

COMPLETED NA

Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System

NCT02758054

COMPLETED NA

SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma

NCT02986867

COMPLETED NA

Heart Rate Evaluation and Resuscitation Trial in Preterm Neonates

NCT03133663

COMPLETED

Optimal Positioning of Nasopharyngeal Temp Probe

NCT02963285

COMPLETED NA

High-Flow Nasal Cannula and Desaturation Episodes in the Morbidly Obese Patients

NCT03148262

TERMINATED Phase 4

Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery

NCT03115151

COMPLETED Phase 3

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

NCT03078075

COMPLETED

Respiratory Effects of Obesity in Children

NCT03376880

COMPLETED

Quantifying Activity Using Wireless Wearable Technology

NCT03277118

COMPLETED Phase 4

Serratus Anterior Plane Block in Patients Undergoing Mastectomy

NCT03154658

COMPLETED NA

End-of-Life Care for African Americans: An Outpatient Intervention

NCT03626402

TERMINATED Phase 2

Rapid Antidepressant Effects of Leucine

NCT03079297

COMPLETED Phase 2

SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients

NCT03065179

COMPLETED Phase 4

Brexpiprazole for Bipolar Depression

NCT03427892

TERMINATED NA

Cranial Electrical Stimulation (CES) as Treatment for Insomnia in Patients With Subacute Stroke

NCT03344562

COMPLETED NA

The Effectiveness of Self-thoracic Spine Mobilization on Improving Sleep Quality in Patients Who Have Shoulder Pain

NCT03088085

COMPLETED Phase 2

Risk Reduction for Alzheimer's Disease

NCT02913664

TERMINATED Phase 4

Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy

NCT02946918

TERMINATED NA

[11C]Acetate PET in Patients With Glioma

NCT02986815

COMPLETED Phase 2

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

NCT03067610

COMPLETED Phase 4

Impact of Liraglutide 3.0 on Body Fat Distribution

NCT03038620

COMPLETED Phase 4

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen

NCT02431897

COMPLETED NA

Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)

NCT03075761

COMPLETED Phase 3

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

NCT02918370

COMPLETED Phase 4

Effect of Carvedilol on Exercise Performance in Fontan Patients

NCT02946892

COMPLETED Phase 1

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

NCT02922777

TERMINATED NA

Low-level Laser Therapy in Patients With Chronic Fibromyalgia

NCT02948634

COMPLETED NA

Bracing for Walking in Parkinson's Disease

NCT03192046

← Previous Page 10 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 106
Phase 2 122
Phase 3 28
Phase 4 98

What is open in the University of Texas Southwestern Medical Center pipeline

162 recruiting of 837 indexed (19% open); 503 completed (60%).

Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Hypertension (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Texas Southwestern Medical Center: open-pipeline peers nationwide

Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of Texas Southwestern Medical CenterUniversity of UtahUniversity of ChicagoIndiana UniversityDana-Farber Cancer InstituteCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalAnn & Robert H Lurie Children's Hospital of ChicagoVanderbilt University Medical Center
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 837 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Texas Southwestern Medical Center page

837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.

  • 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.